Sign in
CDTX Stock Price, Chart, Stats & News
Cidara Therapeutics, Inc.
Save
5.61B
Market cap
–
Current P/E
5.75x
Forward P/E
CDTX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -35.62% |
ROE | -60.15% |
D/E | 0.00x |
Interest coverage ratio | – |
CDTX valuation
P/E | – |
P/S | – |
P/B | 8.15x |
P/CF | -25.89x |
P/FCF | -42.23x |
P/OCF | -25.89x |
PEG | 2.86x |
EV multiple | -31.10x |
About
Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U. S.
Similar securities
Based on sector and market capitalization
Report issue